M&A Deal Summary

Worg Pharmaceuticals Acquires Diater

On November 7, 2023, Worg Pharmaceuticals acquired life science company Diater from Nazca Capital for 150M EUR

Acquisition Highlights
  • This is Worg Pharmaceuticals’ 1st transaction in the Life Science sector.
  • This is Worg Pharmaceuticals’ largest (disclosed) transaction.
  • This is Worg Pharmaceuticals’ 1st transaction in Spain.

M&A Deal Summary
Date 2023-11-07
Target Diater
Sector Life Science
Buyer(s) Worg Pharmaceuticals
Sellers(s) Nazca Capital
Deal Type Add-on Acquisition
Deal Value 150M EUR

Target

Diater

Leganés, Spain
Diater is a bio-pharmaceutical company, specialized in allergy , which offers the doctor and the patient a wide range of diagnostic and treatment products, with the aim of significantly improving the quality of life of the allergic patient. Diater was founded in 1999 and is based in Leganés, Spain.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Worg Pharmaceuticals

Shanghai, China
Category Company
Founded 2018
Sector Life Science
DESCRIPTION

Worg Pharmaceuticals is a clinical stage biopharmaceutical company focusing on delivering transformative immunotherapies to effectively fight against allergic, autoimmune diseases and other indications with high unmet medical needs. Worg Pharmaceuticals was founded in 2018 and is based in Shanghai, China.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (Spain) 1 of 1
Year (2023) 1 of 1
Size (of disclosed) 1 of 1

Seller(S) 1

SELLER

Nazca Capital

Madrid, Spain

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2001
PE ASSETS 755M EUR
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Nazca Private Equity is an investment firm focused on investing in private, small and medium-sized Spanish companies. Nazca looks for businesses with value-added products or services, proven track records, leading market positions, and sustainable competitive advantages. Prospective companies generally have sales of €10 to €300 million. The Firm's target investment size is €7 to €50 million. Funds are typically used to support buyouts, growth capital financings, add-ons, and consolidations. Nazca began investing in 2001 and is based in Madrid.

DEAL STATS #
Overall 27 of 28
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 12 of 13
Country (Spain) 27 of 28
Year (2023) 2 of 2
Size (of disclosed) 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-07-19 Eurocebollas

Valencia, Spain

Eurocebollas produces more than 160 different recipes for onions, both conventional and organic, in different packages (aseptic, heat-sealed bags and cans) that are kept at room temperature and are ready to use in their customers' recipes. Eurocebollas is based in Valencia, Spain.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-04-25 Global Factor

Bilbao, Spain

Global Factor is an international group offering specialised services in energy, climate change and sustainability. Global Factor was founded in 2004 and is based in Bilbao, Spain.

Buy -
Mergr

Product

Company

Legal